Swamy Yeleswaram
Förmögenhet: 10 M $ per 2026-05-31
Förmögenhet: 10 M $ per 2026-05-31
Swamy Yeleswaram was the founder of Incyte Corp., founded in 2002, and held the title of Group Vice President-Drug Metabolism from 2016 to 2022.
Dr. Yeleswaram currently holds the position of Chief Development Officer at Rapport Therapeutics, Inc. since 2023.
Dr. Yeleswaram's education includes a doctorate from the University of British Columbia, a graduate degree from Banaras Hindu University, and an undergraduate degree from Madras Medical College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-17 | 246 426 ( 0,52 % ) | 10 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Företagsledare/Principal | 2023-01-01 |
| Företag | Position | Slut |
|---|---|---|
| INCYTE CORPORATION | Grundare | 2022-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banaras Hindu University
Banaras Hindu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madras Medical College
Madras Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån